TARGETED NANOCARRIERS FOR THE ADMINISTRATION OF IMMUNOSUPPRESSIVE AGENTS
- 专利权人:
- 发明人:
- Ann-Marie Broome,Suraj Dixit,Satish Nadig,Carl Atkinson
- 申请号：
- US15107536
- 公开号：
- US20160317670A1
- 申请日:
- 2015.01.14
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- Disclosed is a nanocarrier-containing immunosuppressive agent that is targeted to C3 breakdown products, integrin, or a combination thereof, to reduce the deleterious systemic effects of the immunosuppressive agent. Also disclosed is a method for suppressing an allo-immune response in a subject, such as one that can occur after an allograft transplantation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Tolerogenic synthetic nanocarriers that reduce antibody responses
- ADJUVANT IMMUNOTHERAPY FOR THE TREATMENT CANCER, OF CLINICAL MANIFESTATIONS ASSOCIATED WITH THE DISEASES LIKE CACHEXIA AND CORRECTION OF ADVERSE EFFECTS OF DRUGS SUCH AS IMMUNOSUPPRESSION, SECUNDARY CACHEXIA, NEUTROPENIA AND LYMPHOPENIA, COMPRISING THE ASSOCIATION OR COMBINATION OF A BIOLOGICAL RESPONSE MODIFIER SPECIALLY SELECTED AND OTHER SUBSTANCES WITH ANTINEOPLASTIC ACTION AND/OR OTHER TREATMENTS
- JAK Immunosuppression composition comprising JAK inhibitor
- Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with diseases like cachexia and correction of adverse effects of drugs such as immunosuppression, neutropenia and lymphopenia, comprising the association or combination of a biological response modifier specially selected and other substances with antineoplastic action and/or other treatments
- COMPOSITIONS ET PROCÉDÉS DIMMUNOTHÉRAPIE
